Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load

Hepatology Research

Volumn 37, Issue 9, 2007, Pages 701-710

  Fujiwara, Kenji ^a   Kaneko, Shuichi ^b   Kakumu, Shinichi ^c   Sata, Michio ^d   Hige, Shuhei ^e   Tomita, Eiichi ^f   Mochida, Satoshi ^a   Ide, T ^d   Nishida, H ^d   Yokoyama, H ^b   Yamashita, T ^b   Moriwaki, H ^h   Nagaki, M ^h   Sugihara, J ^f   Takahashi, H ^f   Ishikawa, T ^c   Miyata, M ^c   Nishikawa, K ^c   Nagoshi, S ^g   Sugahara, S ^g   Yamamoto, K ⁱ   Mizuta, T ⁱ   Ando, T ⁱ   Takei, Y ^j   Enomoto, N ^j   Tsuda, H ^j   Sumino, Y ^k   Ishii, K ^k   Saisho, H ^l   Yokosuka, O ^l   Eguchi, K ^m   Hamasaki, K ^m   Sawada, K ⁿ   Fukunaga, K ⁿ   Arakawa, Y ^o   Moriyama, M ^o   Imawari, M ^p   Ito, T ^p   more..

^a YOKOHAMA ROSAI HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f Gifu Municipal Hospital   (Japan)

^g SAITAMA MEDICAL UNIVERSITY   (Japan)

^h GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ SAGA UNIVERSITY   (Japan)

^j JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^m NAGASAKI UNIVERSITY   (Japan)

ⁿ HYOGO COLLEGE OF MEDICINE   (Japan)

^o NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^p SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Combination therapy; Double filtration plasmapheresis; Early viral reduction; Non responder; Relapser; Sustained virus response

Indexed keywords

ALPHA2B INTERFERON; ATROPINE; METOCLOPRAMIDE; OXYGEN; PEGINTERFERON ALPHA2B; RIBAVIRIN; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CHILL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOUBLE FILTRATION PLASMAPHERESIS; FEMALE; FEVER; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NAUSEA; PAIN; PATIENT DECISION MAKING; PATIENT SAFETY; PLASMAPHERESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELAPSE; TREATMENT RESPONSE; UNCONSCIOUSNESS; VAGUS REFLEX; VIRUS LOAD; VOMITING;

EID: 34447318054     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00117.x     Document Type: Article

References (31)

1. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-5.
2. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-6.
3. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39: 1147-71.
4. Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomized trial. Lancet 2001; 358: 958-65.
5. Fried MW, Shiffman ML, Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-82.
6. Fabrizi F, Martin P, Dixit V et al. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis 2000; 35: 122-9.
7. Manzin A, Candela M, Solforosi L, Gabrielli A, Clementi M. Dynamics of hepatitis C viremia after plasma exchange. J Hepatol 1999; 31: 389-93.
8. Ramratnam B, Bonhoeffer S, Binley J et al. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 1999; 354: 1782-5.
9. Schettler V, Monazahian M, Wieland E, Thomssen R, Müller GA. Effect of heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) apheresis on hepatitis C plasma virus load. Ther Apher 2001; 5: 384-6.
10. Schettler V, Monazahian M, Wieland E et al. Reduction of hepatitis C virus load by H.E.L.P.-LDL apheresis. Eur J Clin Invest 2001; 31: 154-5.
11. Marson P, Boschetto R, De Silvestro G et al. Changes in HCV viremia following LDL apheresis in a HCV positive patient with familial hypercholesterolemia. Int J Artif Organs 1999; 22: 640-4.
12. Ishida H, Tanabe K, Tokumoto T et al. Hepatitis C virus decrease in patients with maintenance hemofiltration therapy. Artif Organs 2004; 28: 316-18.
13. Diepolder HM, Kashiwagi N, Teuber G etal. Leucocytapheresis with Adacolumn enhances HCV-specific proliferative responses in patients infected with hepatitis C virus genotype 1. J Med Virol 2005; 77: 209-15.
14. Sawada K, Masaki N, Hayashi S et al. Immunomodulatory effects of selective leucocytapheresis as a new adjunct to interferon-α2b plus ribavirin combination therapy: A prospective study in patients with high plasma HCV viraemia. J Viral Hepat 2005; 12: 274-82.
15. Moriyama M, Kaneko M, Matsumura H et al. Removal of hepatitis C virus by G-1 beads in sera from patients with chronic hepatitis C. Intervirology 2005; 48: 84-8.
16. Hayashi N, Takehara T. Antiviral therapy for chronic hepatitis C: Past, present, and future. J Gastroenterol 2006; 41: 17-27.
17. Ballesteros AL, Fuster D, Planas R, Clotet B, Tural C. Role of viral kinetics under HCV therapy in HIV/HCV-coinfected patients. J Antimicrob Chemother 2005; 55: 824-7.
18. Sakai A, Kaneko S, Matsushita E, Kobayashi K. Floating density of hepatitis C virus particles and response to interferon treatment. J Med Virol 1998; 55: 12-17.
19. Sakai A, Kaneko S, Kobayashi K. Immunoadsorption therapy for HCV infected chimpanzee. Nippon Rinsho 2001; 59: 1374-8.
20. Yamashita T, Arai K, Sakai A et al. Virological effects and safety of combined double filtration plasmapheresis (DFPP) and interferon therapy in patients with chronic hepatitis C. A preliminary study. Hepatol Res 2006; 36: 167-75.
21. Tsubota A, Arase Y, Suzuki Y etal. Igaku to Yakugaku. J Med Pharm Sci 2004; 51: 159-66.
22. Klingel R, Fassbender C, Fassbender T, Erdtracht B, Berrouschot J. Rheopheresis: Rheologic, functional, and structural aspects. Therap Apher 2000; 4: 348-57.
23. Klingel R, Fassbender C, Faßbender T, Gohlen B. Clinical studies to implement Rheopheresis for age-related macular degeneration guided by evidence-based-medicine. Transfus Apher Sci 2003; 29: 71-84.
24. Soza A, Everhart JE, Ghany MG et al. Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C. Hepatology 2002; 36: 1273-9.
25. Kaito M, Watanabe S, Tsukiyama-Kohara K et al. Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol 1994; 75: 1755-60.
26. Nakaji S, Yamamoto T. Membranes for therapeutic apheresis. Therap Apher 2002; 6: 267-70.
27. Neumann AU, Lam NP, Dahari H et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy. Science 1998; 282: 103-7.
28. Hijikata M, Shimizu Y, Kato H et al. Equilibrium centrifugation studies of hepatitis C virus: Evidence for circulating immune complexes. J Virol 1993; 67: 1953-8.
29. Thomssen R, Bonk S, Thiele A. Density heterogeneities of hepatitis C virus in human sera due to the binding of-β-lipoproteins and immunoglobulins. Med Microbiol Immumol 1993; 182: 329-34.
30. Kanto T, Hayashi N, Takehara T et al. Buoyant density of hepatitis C virus recovered from infected hosts: Two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation. Hepatology 1994; 19: 296-302.
31. Davis G. Monitoring of viral levels during therapy of hepatitis C. Hepatology 2002; 36: S145-S151.